Fusion event
HBV-MEF2C-AS1 integration
Detection method
PCR and Sanger sequencing
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GAAACTGCACTTGTATTCCCATCCCATCATCCTGGGCTTTCGCAAGATTCCTATGGGAGTGGGCCTCAGTCCGTTTCTCCTGGCTCAGTTTACTAGTGCC| |ATTTGTTCAGTGGTTCGTAGGGCTTTCCCCCACTGTTTGGCTTTCAGCTATATGGATGATGTGGTATTGGGGGCCAAGTCTGTACAACATCTTGAGTCCC
End
88754909/89459092 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/792153; hsa-mir-103a-1/Downstream/557529;
Upstream sequence
CGGGGAGCGCGCGGCATCGCGGGGGTGGCCGGGGCCAGGGCTTCCCACGTGCGCAGCAGGACGCAGCGCTGCCTGAAACTCGCGCCGCGAGGAGAgggcg
Downstream sequence
AATAGGTTTGTGATATTTTCAGTTCTGATTTTTAATATTTATTGCAATATGTTTTGTAAAATTCTAAAAATAAAGATAGATGAATTACCTACTGTAAGAT
Fujimoto, A., et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet,2012, 44(7): 760-764.